[go: up one dir, main page]

WO2011161465A3 - Composition pour le traitement de la peau - Google Patents

Composition pour le traitement de la peau Download PDF

Info

Publication number
WO2011161465A3
WO2011161465A3 PCT/GB2011/051191 GB2011051191W WO2011161465A3 WO 2011161465 A3 WO2011161465 A3 WO 2011161465A3 GB 2011051191 W GB2011051191 W GB 2011051191W WO 2011161465 A3 WO2011161465 A3 WO 2011161465A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
skin
treatment
ester
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2011/051191
Other languages
English (en)
Other versions
WO2011161465A2 (fr
Inventor
Keith Coupland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SEEDS GROUP LP
Original Assignee
SEEDS GROUP LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SEEDS GROUP LP filed Critical SEEDS GROUP LP
Publication of WO2011161465A2 publication Critical patent/WO2011161465A2/fr
Publication of WO2011161465A3 publication Critical patent/WO2011161465A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composition comprenant (i) de l'acide stéaridonique, ou un ester de celui-ci, et éventuellement, (ii) un acide octadécatriénoïque conjugué ou un ester de celui-ci, destinée à être utilisée pour stimuler la synthèse de la sirtuine dans les cellules cutanées.
PCT/GB2011/051191 2010-06-24 2011-06-24 Composition pour le traitement de la peau Ceased WO2011161465A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1010638.3A GB201010638D0 (en) 2010-06-24 2010-06-24 Composition for treatment of skin
GB1010638.3 2010-06-24

Publications (2)

Publication Number Publication Date
WO2011161465A2 WO2011161465A2 (fr) 2011-12-29
WO2011161465A3 true WO2011161465A3 (fr) 2012-08-23

Family

ID=42582925

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2011/051191 Ceased WO2011161465A2 (fr) 2010-06-24 2011-06-24 Composition pour le traitement de la peau

Country Status (2)

Country Link
GB (1) GB201010638D0 (fr)
WO (1) WO2011161465A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9801900B2 (en) 2013-11-22 2017-10-31 Mary Kay Inc. Compositions for sensitive skin

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6340485B1 (en) * 1996-06-03 2002-01-22 Croda International Plc Compositions and uses thereof
US20080213357A1 (en) * 2007-02-12 2008-09-04 Andrew Bruce Hebard Plant Derived Lipid Useful for Nutraceutical and Cosemeceutical Applications
WO2010013015A2 (fr) * 2008-08-01 2010-02-04 E.S.L.I. Limited Composition permettant une production accélérée de collagène

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2972497A (en) 1996-06-03 1998-01-05 Croda International Plc Treatment of oils
GB0902040D0 (en) 2009-02-06 2009-03-11 Seeds Lp Composition for treatment of skin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6340485B1 (en) * 1996-06-03 2002-01-22 Croda International Plc Compositions and uses thereof
US20080213357A1 (en) * 2007-02-12 2008-09-04 Andrew Bruce Hebard Plant Derived Lipid Useful for Nutraceutical and Cosemeceutical Applications
WO2010013015A2 (fr) * 2008-08-01 2010-02-04 E.S.L.I. Limited Composition permettant une production accélérée de collagène

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CONG CAO ET AL: "SIRT1 confers protection against UVB- and H2O2-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes", JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, UNIVERSITY PRESS CAROL DAVILA, BUCHAREST, RO, vol. 13, no. 9B, 1 September 2009 (2009-09-01), pages 3632 - 3643, XP009160306, ISSN: 1582-1838, [retrieved on 20080804], DOI: 10.1111/J.1582-4934.2008.00453.X *
MOREAU, M. ET AL.: "Enhancing cell longevity for cosmetic applications: a complimentary approach", J DRUGS DERMATOL, vol. 6, no. 6, June 2007 (2007-06-01), pages 14 - 19, XP009144734 *

Also Published As

Publication number Publication date
GB201010638D0 (en) 2010-08-11
WO2011161465A2 (fr) 2011-12-29

Similar Documents

Publication Publication Date Title
WO2010151698A3 (fr) Dispositifs médicaux d'administration orientables et procédés d'utilisation
WO2010111409A3 (fr) Cellules souches pluripotentes
EP2318033B8 (fr) Compositions destinées au traitement de la douleur et/ou de l'inflammation
WO2012030993A3 (fr) Compositions pour la peau et leurs applications
WO2009089494A3 (fr) Compositions pharmaceutiques
WO2012055567A3 (fr) Utilisation de malononitrilamides dans la douleur neuropathique
WO2010141417A3 (fr) Systèmes et méthodes d'altération de la fonction du tissu du muscle lisse
IL212560A0 (en) Combination of an oxidant and a photoactivator for the healing of wounds
EP2282746B8 (fr) Compositions et méthodes utilisant des cellules souches dans la cicatrisation de plaies cutanées
WO2010062863A3 (fr) Compositions contenant des satiogènes et leurs procédés d'utilisation
WO2010132882A3 (fr) Compositions sublinguales de dexmédétomidine et leurs procédés d'utilisation
WO2011085162A3 (fr) Compositions topiques transdermiques de dexmédétomidine et leurs procédés d'utilisation
WO2013144811A3 (fr) Procédés et compositions pour traiter l'inflammation
WO2009095261A3 (fr) Compositions vaccinales
WO2012073047A3 (fr) Compositions et procédés
ZA200907240B (en) Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods
WO2011126842A3 (fr) Ciblage de micro-arn pour le traitement de troubles cardiaques
EP2575842A4 (fr) Composition comprenant l'extrait de physalis alkekengi var. francheti hort en tant que principe actif pour la prévention et le traitement de maladies inflammatoires
SG10201408374WA (en) Therapeutic Combinations Of Theobromine And An Antihistamine
NZ595440A (en) Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds
WO2011130697A3 (fr) Ciblage tissulaire
WO2011091154A3 (fr) Utilisation d'érythrocytes humains dans la prévention et le traitement de la dissémination et de la croissance du cancer
WO2011130692A3 (fr) Inhibiteurs du stress oxydatif induit par les androgènes
WO2011156820A9 (fr) Compositions, méthodes et utilisations pour le traitement du diabète insulino-dépendant
EP2381945A4 (fr) Formules topiques d'inhibiteurs de flap pour le traitement des maladies dermatologiques

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11736440

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11736440

Country of ref document: EP

Kind code of ref document: A2